Summary
A company named WellTheory, which focuses on autoimmune care using artificial intelligence (AI), has raised an additional $14 million from investors, reaching a total of $26.2 million. The recent funding round was led by General Catalyst and included backing from investors such as 7wire Ventures and Ingeborg Investments, all of which had female partners. This funding will help WellTheory grow commercially and develop its AI technology further.
Key Facts
- WellTheory is a startup that uses AI to provide care for autoimmune diseases.
- The company recently raised $14 million, bringing its total funding to $26.2 million.
- The funding round was led by General Catalyst, and all investors involved had female partners.
- WellTheory plans to use the new funds to grow its business and advance its AI technology.
- Ellen Rudolph, who founded WellTheory, has personal experience with autoimmune disease.
- The company already partners with large employers and health plans to offer its services.
- More than 50 million Americans are affected by autoimmune diseases.
- Diagnosing autoimmune diseases can take over four years and consultations with multiple doctors.
